• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Deeptha Rajkumar

The Dabur Pharma counter ruled firm during early trade but ended relatively flat, absorbing some of the day's bearish market sentiment.

Brokers said steady institutional interest had been propping up the stock. Given its low float, any sustained interest could trigger a sharp upswing. Analysts attribute market interest to anticipation of positive news from the company regarding its US business.

Touting it as a value pick, an analyst said that the company could see revenues increase two-and-a-half times by fiscal 2008.

The stock ended at Rs 64.55, losing ground by 0.69 per cent on the BSE. A total of 3.13 lakh shares were traded.

More Stories on : Stocks | Ear to the ground

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Tata MF launches Equity Management Fund

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line